Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Veterinario de OncoLink / Tumores
Supported by the Savannah and Barry French Poodle Memorial Fund
University of Pennsylvania School of Veterinary Medicine
Ultima Vez Modificado: 21 de agosto del 2005
Michael H. Goldschmidt, MSc, BVMS, MRCVS, Diplomate ACVP Professor and Head, Laboratory of Pathology and Toxicology Chief, Surgical Pathology Department of Pathobiology
Frances S. Shofer, PhD, Adjunct Associate Professor of Epidemiology and Biostatistics
Melanocytes are derived from neural crest cells. Precursor cells migrate from the neural crest to the epidermis in utero. The melanocytes develop dendritic cell processes and produce intracytoplasmic pigment granules. They send their dendritic processes up in between the keratinocytes and transfer the melanin to the keratinocytes.
Normal melanocytes inhabit the basal layer of the skin and the bulb of the hair follicle.
The two terms below are used to classify some of the different types of melanomas.
Junctional activity: the proliferation of nests or th èques (aggregations) of melanocytes along the dermo-epidermal junction.
Compound tumor: indicates that there is a junctional and an intradermal component to the tumor.
Melanocytic neoplasms can either be benign or malignant. To distinguish benign from malignant in dogs the following should be evaluated:
All histopathologic sections should be bleached prior to evaluation as the nuclear morphology may be obscured by the intracytoplasmic melanin granules.
Definition: A benign tumor arising from melanocytes either in the epidermis, dermis, or adnexa, primarily the external root sheath of the hair follicles.
Synonyms: Cutaneous Melanoma, Dermal Melanoma, Benign Melanoma
| Sex | N | Percent |
| Female |
637
|
17% (21%)
|
| Female Spayed |
1254
|
32% (33%)
|
| Male |
1084
|
28% (25%)
|
| Male Castrated |
881
|
23% (21%)
|
| ( Normal Population %) |
|
|
| Breeds at Increased Risk |
N | Probability | OR | 95% Confidence Interval |
|
| Vizsla |
70
|
<0.0001
|
7.5
|
5.83
|
9.61
|
| Irish Terrier |
7
|
0.0002
|
6.7
|
3.06
|
14.52
|
| Miniature Schnauzer |
306
|
<0.0001
|
6.4
|
5.67
|
7.23
|
| Standard Schnauzer |
137
|
<0.0001
|
5.0
|
4.21
|
6.00
|
| Bedlington Terrier |
6
|
0.0021
|
4.9
|
2.12
|
11.13
|
| Australian Terrier |
8
|
0.0016
|
3.9
|
1.89
|
7.89
|
| Silky Terrier |
11
|
0.0002
|
3.9
|
2.09
|
7.08
|
| Chesapeake Bay Retriever |
34
|
<0.0001
|
3.6
|
2.54
|
5.08
|
| Airedale Terrier |
65
|
<0.0001
|
3.6
|
2.76
|
4.57
|
| Shar-Pei |
75
|
<0.0001
|
3.4
|
2.67
|
4.27
|
| Doberman Pinscher |
323
|
<0.0001
|
3.3
|
2.96
|
3.73
|
| Irish Setter |
87
|
<0.0001
|
3.3
|
2.66
|
4.11
|
| Rhodesian Ridgeback |
31
|
<0.0001
|
3.2
|
2.25
|
4.64
|
| Bloodhound |
11
|
0.0018
|
3.0
|
1.63
|
5.46
|
| Giant Schnauzer |
13
|
0.0013
|
2.8
|
1.59
|
4.83
|
| Norfolk/Norwich Terrier |
5
|
0.0482
|
2.6
|
1.07
|
6.38
|
| Brittany |
49
|
<0.0001
|
2.6
|
1.92
|
3.42
|
| Golden Retriever |
538
|
<0.0001
|
2.1
|
1.94
|
2.34
|
| Bouvier des Flandres |
15
|
0.0139
|
2.0
|
1.22
|
3.42
|
| Rottweiler |
156
|
<0.0001
|
1.9
|
1.59
|
2.20
|
| Cairn Terrier |
32
|
0.0027
|
1.8
|
1.26
|
2.56
|
| Chow Chow |
26
|
0.0090
|
1.7
|
1.17
|
2.57
|
| Scottish Terrier |
41
|
0.0158
|
1.5
|
1.10
|
2.04
|
| Breeds at Decreased Risk |
N | Probability | OR | 95% Confidence Interval |
|
| German Shepherd |
113
|
0.0001
|
0.7
|
0.58
|
0.84
|
| Mixed Breed |
673
|
<0.0001
|
0.7
|
0.62
|
0.73
|
| Labrador Retriever |
184
|
<0.0001
|
0.6
|
0.49
|
0.66
|
| Lhasa Apso |
24
|
0.0029
|
0.6
|
0.38
|
0.84
|
| English Setter |
7
|
0.0355
|
0.5
|
0.22
|
0.98
|
| German Shorthaired Pointer |
11
|
0.0039
|
0.4
|
0.25
|
0.81
|
| Great Dane |
12
|
0.0017
|
0.4
|
0.25
|
0.78
|
| West Highland White Terrier |
16
|
0.0002
|
0.4
|
0.26
|
0.70
|
| Miniature Poodle |
42
|
<0.0001
|
0.4
|
0.31
|
0.58
|
| Cocker Spaniel |
74
|
<0.0001
|
0.4
|
0.33
|
0.53
|
| Collie |
13
|
0.0002
|
0.4
|
0.23
|
0.69
|
| Greyhound |
6
|
0.0102
|
0.4
|
0.17
|
0.84
|
| English Springer Spaniel |
23
|
<0.0001
|
0.4
|
0.25
|
0.56
|
| Pug |
6
|
0.0056
|
0.4
|
0.16
|
0.81
|
| Beagle |
29
|
<0.0001
|
0.4
|
0.25
|
0.51
|
| Toy Poodle |
5
|
0.0041
|
0.3
|
0.14
|
0.78
|
| Weimeraner |
5
|
0.0004
|
0.3
|
0.11
|
0.64
|
| Border Collie |
3
|
0.0093
|
0.3
|
0.08
|
0.82
|
| Shih Tzu |
15
|
<0.0001
|
0.3
|
0.15
|
0.43
|
| Cardigan Welsh Corgi |
2
|
0.0213
|
0.2
|
0.06
|
0.94
|
| Basset Hound |
9
|
<0.0001
|
0.2
|
0.12
|
0.44
|
| Pomeranian |
3
|
0.0007
|
0.2
|
0.07
|
0.65
|
| Shetland Sheepdog |
15
|
<0.0001
|
0.2
|
0.12
|
0.33
|
| Keeshond |
3
|
0.0004
|
0.2
|
0.06
|
0.61
|
| Boston Terrier |
3
|
<0.0001
|
0.1
|
0.05
|
0.44
|
| Norwegian Elkhound |
1
|
0.0062
|
0.1
|
0.02
|
0.88
|
| Maltese |
2
|
<0.0001
|
0.1
|
0.03
|
0.45
|
| Jack Russell Terrier |
2
|
<0.0001
|
0.1
|
0.03
|
0.42
|
| Husky |
5
|
<0.0001
|
0.1
|
0.04
|
0.21
|
| Bichon Frise |
2
|
<0.0001
|
0.1
|
0.02
|
0.28
|
| Dalmatian |
2
|
<0.0001
|
0.1
|
0.02
|
0.26
|
| Old English Sheepdog |
1
|
<0.0001
|
0.1
|
0.01
|
0.37
|
| Site | Percent |
| Head |
28.5%
|
| Forelimb |
20.5%
|
| Hindlimb |
12.4%
|
| Thorax |
9.8%
|
| Abdomen |
7.9%
|
| Back |
6.8%
|
| Multiple |
5.3%
|
| Neck |
4.1%
|
| Perineum |
2.2%
|
| Scrotum |
1.3%
|
| Tail |
1.2%
|

Histopathology
Balloon Cell Melanocytoma: This uncommon variant is composed of large, round and epithelioid cells that have abundant pale, finely granular-to-foamy cytoplasm. Melanin granules can be very difficult to find in these cells.
The site of origin and histopathologic appearance is what distinguishes melanocytomas from the more serious malignant melanoma. Wide surgical excision is curative for the cutaneous form.
Definition: A tumor with features of a compound melanocytoma and a benign epithelial neoplasm.
These tumors are rare.
Ms. Hollis discusses the role of the nurse practitioner in oncology care. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

